Department of Infection, Immunity & Cardiovascular Disease
The Department of Infection, Immunity and Cardiovascular Disease was formed in September 2015 following the merger of the former Departments of Cardiovascular Science and Infection and Immunity bringing together research strengths in inflammation, medical and biomedical imaging, discovery science using experimental model systems and cardiopulmonary medicine in particular. This exciting new development arose in part from the Tooke Review of Biomedical Life Sciences carried out by Sir John Tooke in 2014.
Our research broadly seeks to understand mechanisms of inflammation in the context of lung, heart and, more recently, brain disease. Our research encompasses a global priority, Infectious Disease, in which we seek to understand the interactions between infective bacteria and the immune system.